Premium Only Content
This video is only available to Rumble Premium subscribers. Subscribe to
enjoy exclusive content and ad-free viewing.
1 on 1 with Michelle | Dr. Chris Shaw | Day 1 Vancouver
9 months ago
51
NCI
Canada
Vancouver
British Columbia
COVID
COVID 19
COVID Vaccine
Neurological
Neurologist
Truth Matters
Expert
Michelle Leduc Catlin interviews Dr. Chris Shaw after his expert testimony at the National Citizens Inquiry, where he covers the neurological consequences of COVID-19 vaccination on the population. Dr. Shaw expresses concerns about potential loss of professionals in British Columbia and Canada due to these consequences. As a researcher on Lou Gherig's disease, Dr. Shaw's research was halted after refusing the vaccine, which crosses cell membrane barriers, including entering the brain, increasing the risk of neurological disorders.
Loading comments...
-
2:25
National Citizens Inquiry Canada | NCI Clips
1 month agoVaccine Distribution Exposed
9866 -
56:08
State of the Second Podcast
22 hours agoWhat does the next 4 years look like for the suppressor market? (Ft. Rugged Suppressors)
88.9K13 -
29:08
The Lou Holtz Show
16 hours agoThe Lou Holtz Show Ep 21 | Enes Kanter Freedom: A Voice For Human Rights #podcast
90.3K3 -
28:31
America First Policy Institute
23 hours agoAmerica First Policy Institute Gala Donald Trump, Elon Musk & Sylvester Stallone Ignite the Movement
53.3K18 -
4:36
BIG NEM
14 hours agoThe Sad Truth About How Our Cannabis is Grown
51.2K22 -
3:07:08
Price of Reason
18 hours agoMainstream Media FEARS Extinction! Gladiator 2 Review! New DnD SCANDAL!
73.6K12 -
8:23:44
Fresh and Fit
15 hours agoIsrael-Hezbollah Ceasefire & Reacting To Death Threats On X
178K75 -
1:11:10
Steve-O's Wild Ride! Podcast
5 days ago $10.58 earnedDusty Slay Went From Selling Pesticides To Having A Netflix Special - Wild Ride #244
64.9K3 -
1:16:02
CocktailsConsoles
12 hours agoBE PART OF THE GAME!!| Death Road to Canada | Cocktails & Consoles Livestream
45.7K3 -
8:19:28
Phyxicx
15 hours agoWe're streaming again! - 11/26/2024
38.7K